FR2449449A2 - Chanodesethyl apovincamine(s) - for the treatment of cardio:circulatory and cerebrovascular disorders - Google Patents

Chanodesethyl apovincamine(s) - for the treatment of cardio:circulatory and cerebrovascular disorders

Info

Publication number
FR2449449A2
FR2449449A2 FR7900570A FR7900570A FR2449449A2 FR 2449449 A2 FR2449449 A2 FR 2449449A2 FR 7900570 A FR7900570 A FR 7900570A FR 7900570 A FR7900570 A FR 7900570A FR 2449449 A2 FR2449449 A2 FR 2449449A2
Authority
FR
France
Prior art keywords
apovincamine
cardio
circulatory
chanodesethyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7900570A
Other languages
French (fr)
Other versions
FR2449449B2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omnium Chimique SA
Original Assignee
Omnium Chimique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB7838281A external-priority patent/GB2005267B/en
Application filed by Omnium Chimique SA filed Critical Omnium Chimique SA
Publication of FR2449449A2 publication Critical patent/FR2449449A2/en
Application granted granted Critical
Publication of FR2449449B2 publication Critical patent/FR2449449B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Abstract

Cardio-circulatory and cerebero-vasculatory disorders are treated by administration of a chonodesethyl apovincamine of formula (I) or a pharmaceutically-acceptable salt of (I) (where R = H, satd. or unsatd. straight or branched 1-5C alkyl, or benzyl; Z = H, halogen, alkyl, OH, acyloxy, carbamate, or methoxy), together with a pharmaceutical vehicle or excipient. This is an addn. to FR 77.29574, which covers (I) per se. (I; R = C2H5; Z = H) is specifically claimed. (I) may be given as tablets, capsules or injectable solns. in a unit dosage of 0.5-700 mg.
FR7900570A 1978-09-27 1979-01-10 Chanodesethyl apovincamine(s) - for the treatment of cardio:circulatory and cerebrovascular disorders Granted FR2449449A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7838281A GB2005267B (en) 1977-09-30 1978-09-27 Indole derivatives their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
FR2449449A2 true FR2449449A2 (en) 1980-09-19
FR2449449B2 FR2449449B2 (en) 1985-04-12

Family

ID=10499931

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7900570A Granted FR2449449A2 (en) 1978-09-27 1979-01-10 Chanodesethyl apovincamine(s) - for the treatment of cardio:circulatory and cerebrovascular disorders
FR8121995A Granted FR2500834A2 (en) 1978-09-27 1981-11-24 N-ETHYL CHANODESETHYLAPOVINCAMINE USEFUL AS MEDICINES

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8121995A Granted FR2500834A2 (en) 1978-09-27 1981-11-24 N-ETHYL CHANODESETHYLAPOVINCAMINE USEFUL AS MEDICINES

Country Status (1)

Country Link
FR (2) FR2449449A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617305A (en) * 1983-02-25 1986-10-14 Omnichem, S.A. 4-alkylindolonaphthyridines and their therapeutical application

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3207775A1 (en) * 1981-03-13 1982-09-23 Sandoz-Patent-GmbH, 7850 Lörrach METHOD FOR PRODUCING MOTHER-CORNAL CALOIDS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376150A1 (en) * 1976-12-31 1978-07-28 Logeais Labor Jacques THERAPEUTIC COMPOSITIONS BASED ON HEXAHYDRO-1,2,3,3A, 4,5-CANTHINE DERIVATIVES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2376150A1 (en) * 1976-12-31 1978-07-28 Logeais Labor Jacques THERAPEUTIC COMPOSITIONS BASED ON HEXAHYDRO-1,2,3,3A, 4,5-CANTHINE DERIVATIVES

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617305A (en) * 1983-02-25 1986-10-14 Omnichem, S.A. 4-alkylindolonaphthyridines and their therapeutical application

Also Published As

Publication number Publication date
FR2500834B2 (en) 1984-12-21
FR2449449B2 (en) 1985-04-12
FR2500834A2 (en) 1982-09-03

Similar Documents

Publication Publication Date Title
DE3170684D1 (en) An orally administered drug form comprising a polar bioactive agent and an adjuvant
IE790951L (en) Carnitine solution
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
IT8224839A0 (en) REACTIVE POLYMERS FOR THE TREATMENT OF SKIN DISEASES.
GB8326878D0 (en) Administering medicaments to patients
GB8602264D0 (en) Administering medicaments to patients
ZA793394B (en) Platinum-diamine complexes,a method for the preparation thereof,a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer,as well as a medicine thus formed
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
SE7612534L (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICALS FOR THE TREATMENT OF CALCIUM SUBSTANCE DEFICIENCIES
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
DK541189D0 (en) USE OF NALMEFEN OR NALTREXON FOR THE PREPARATION OF A MEDICINE FOR THE TREATMENT OF INTERSTITIAL CYSTITIS
EP0112378A4 (en) Electro-optical device for monitoring instantaneous singlet oxygen concentration produced during the treatment of cancer by means of photochemotherapy.
FR2449449A2 (en) Chanodesethyl apovincamine(s) - for the treatment of cardio:circulatory and cerebrovascular disorders
JPS51116092A (en) Footwear for automatically treating defecation of seriously limbs handicapped patient or the like
Bigelow Effects of aqueous pineal extract in chronic schizophrenia.
EP0093497A3 (en) Anthelmintic treatment
JPS57112331A (en) Medical composition of ganoderma lucidum component
IE790157L (en) Therapeutic agents
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
EP0317933A3 (en) Treatment of fibromyalgia
AU2169677A (en) Medicament to be taken orally for regulating the circulation of blood
YU107779A (en) Process for preparing derivatives of benzoylphenoxyalkanoic acid, which normalize the blood lipide level
USD231700S (en) Aeration nozzle for a hydrotherapy unit
JPS57159715A (en) Synergism of analgesic
USD231698S (en) Aeration nozzle for a hydrotherapy unit

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name